Maze Therapeutics, Inc. (MAZE) Institutional Ownership and Insiders Activity

Maze Therapeutics, Inc. (MAZE) is widely held by institutional investors, with 161 firms reporting positions valued at approximately $1.70B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Frazier Life Sciences Management, L.P. is the largest disclosed holder, reporting approximately $150.18M in MAZE holdings in its latest filing.

Recent insider activity includes 7 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.